DGAT2 and hepatocellular carcinoma: It is reported that DGAT2 expression in HCC tissues is lower than that in normal samples and is positively correlated with the survival time of patients (i.e., the higher the expression level, the longer the survival time); hence, it can be used as a potential anticancer target and diagnostic marker [35].